Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-06-01
- Lead Sponsor
- Belx Bio-Pharmaceutical (Taiwan) Corporation
- Target Recruit Count
- 23
- Registration Number
- NCT03256331
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath